AdministrationAgreement-v1.0.1(2018EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.8(EN)|1|AdministrationAgreement-v1.0.1(2018EN)}} <!-- Tot...')
 
Geen bewerkingssamenvatting
Regel 84: Regel 84:
==Information Model==
==Information Model==
<BR>
<BR>
<imagemap> Bestand:AdministrationAgreement-v1.0.1Model(EN).png | center  
<imagemap> Bestand:AdministrationAgreement-v1.0.1Model(2018EN).png | center  
rect 614 489 899 527 [[#AdministrationAgreementAdditionalInformationCodeList]]
rect 624 497 909 535 [[#AdministrationAgreementAdditionalInformationCodeList]]
rect 678 385 899 455 [[#13342]]
rect 688 393 909 463 [[#13342]]
rect 172 190 286 260 [[#13355]]
rect 182 198 296 268 [[#13355]]
rect 172 285 301 355 [[#13345]]
rect 182 293 311 363 [[#13345]]
rect 336 491 555 531 [[#AdministrationAgreementStopTypeCodeList]]
rect 346 499 565 539 [[#AdministrationAgreementStopTypeCodeList]]
rect 355 99 484 169 [[InstructionsForUse-v1.1.1(2018EN)]]
rect 365 107 494 177 [[InstructionsForUse-v1.1.1(2018EN)]]
rect 528 99 657 169 [[MedicationAgreement-v1.0.1(2018EN)]]
rect 538 107 667 177 [[MedicationAgreement-v1.0.1(2018EN)]]
rect 701 99 899 169 [[PharmaceuticalProduct-v2.0(2018EN)]]
rect 711 107 909 177 [[PharmaceuticalProduct-v2.0(2018EN)]]
rect 769 289 899 359 [[#13344]]
rect 779 297 909 367 [[#13344]]
rect 172 95 301 165 [[HealthcareProvider-v3.2(2018EN)]]
rect 182 103 311 173 [[HealthcareProvider-v3.2(2018EN)]]
rect 419 385 579 455 [[#13341]]
rect 429 393 589 463 [[#13341]]
rect 172 380 301 450 [[TimeInterval-v1.0(2018EN)]]
rect 182 388 311 458 [[TimeInterval-v1.0(2018EN)]]
rect 740 194 899 264 [[#13349]]
rect 750 202 909 272 [[#13349]]
rect 480 248 590 318 [[#13347]]
rect 490 256 600 326 [[#13347]]
desc none
desc none
</imagemap>
</imagemap>
Regel 538: Regel 538:
*[[PharmaceuticalProduct-v2.0(2018EN)|PharmaceuticalProduct-v2.0]]
*[[PharmaceuticalProduct-v2.0(2018EN)|PharmaceuticalProduct-v2.0]]
*[[TimeInterval-v1.0(2018EN)|TimeInterval-v1.0]]
*[[TimeInterval-v1.0(2018EN)|TimeInterval-v1.0]]
====This inforation model is used in<!--ftReferredBy-->====
====This information model is used in<!--ftReferredBy-->====
*[[MedicationAdministration2-v1.0.1(2018EN)|MedicationAdministration2-v1.0.1]]
*[[MedicationAdministration2-v1.0.1(2018EN)|MedicationAdministration2-v1.0.1]]
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->==
Regel 557: Regel 557:
</ul>
</ul>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
This page is generated on 01/11/2018 17:37:54 with ZibExtraction v. 2.0.6879.31307<!--ftDate--> <BR>
This page is generated on 23/12/2018 01:19:58 with ZibExtraction v. 3.0.6929.24609<!--ftDate--> <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2018(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2018(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2018(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2018(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Versie van 24 dec 2018 11:56


Attention!! This is not the most recent version of this information model. You can find the most recent version ''here''.

General information

Name: nl.zorg.AdministrationAgreement NL.png
Version: 1.0.1
HCIM Status:Final
Release: 2018
Release status: Prepublished
Release date: 01-10-2018

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Projectgroep Medicatieproces
DCM::ContactInformation.Address
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom
DCM::ContentAuthorList Projectgroep Medicatieproces
DCM::CreationDate 1-2-2017
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.9.8
DCM::KeywordList Medicatie, Toediening
DCM::LifecycleStatus Final
DCM::ModelerList Architectuurgroep Registratie aan de Bron
DCM::Name nl.zorg.Toedieningsafspraak
DCM::PublicationDate 01-10-2018
DCM::PublicationStatus Prepublished
DCM::ReviewerList Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
DCM::RevisionDate 31-12-2017
DCM::Superseeds nl.zorg.MedicatieVerstrekking-v3.0
DCM::Version 1.0.1
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)

ZIB-643 Kleine tekstuele verbeteringen

Concept

An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.

Purpose

The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.

Information Model


#AdministrationAgreementAdditionalInformationCodeList#13342#13355#13345#AdministrationAgreementStopTypeCodeListInstructionsForUse-v1.1.1(2018EN)MedicationAgreement-v1.0.1(2018EN)PharmaceuticalProduct-v2.0(2018EN)#13344HealthcareProvider-v3.2(2018EN)#13341TimeInterval-v1.0(2018EN)#13349#13347AdministrationAgreement-v1.0.1Model(2018EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:9.8.20132 Arrowdown.pngAdministrationAgreement Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model.
Verwijzing.png NL-CM:9.8.22097 Arrowright.pngSupplier::HealthProfessional 0..1 The supplier (pharmacist) that entered the administration agreement.
Block.png HealthcareProvider
Verwijzing.png NL-CM:9.8.20237 Arrowright.pngMedicineForAdministrationAgreement::FarmaceuticalProduct 1 Medicine in the AdministrationAgreement.
Block.png PharmaceuticalProduct
Verwijzing.png NL-CM:9.8.22098 Arrowright.pngInstructionsForUse 0..1 Instructions for administering the medication, e.g. dose and route of administration.
Block.png InstructionsForUse
TS.png NL-CM:9.8.20133 Arrowright.pngAdministrationAgreementDateTime 0..1 The time at which the agreement was made.
ST.png NL-CM:9.8.22499 Arrowright.pngAgreementReason 0..1 Reason for this agreement. This will often be the same reason as the one for the medication agreement.

This field has the option to - if applicable - enter a specific reason for the administration agreement. Examples include: substitution, transfer to GDS, patient request for different product, etc.

Verwijzing.png NL-CM:9.8.22660 Arrowright.pngPeriodOfUse 1 Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original administration agreement. The end date indicates from when the medication is to be discontinued.

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.

End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

With medication for an indefinite period only a start date is indicated.

Block.png TimeInterval
Verwijzing.png NL-CM:9.8.22394 Arrowright.pngMedicationAgreement 0..1 Relationship to the medication agreement on which the administration agreement is based.
Block.png MedicationAgreement
CD.png NL-CM:9.8.22498 Arrowright.pngAdministrationAgreementStopType 0..1 Stop type, the manner in which this medication is discontinued (temporary or definitive).
List2.png AdministrationAgreementStopTypeCodeList
BL.png NL-CM:9.8.23034 Arrowright.pngCanceledIndicator 0..1 In the event of an error correction, this indicator is to be put on for the incorrect agreement.
CD.png NL-CM:9.8.23284 Arrowright.pngAdministrationAgreementAdditionalInformation 0..* Additional information includes details on the structure of the agreement made.

This element mainly contains information that until now has been structured with ZZ rules. The medication-related topics that are now supported by the ZZ rules are best supported with a system functionality. A process has been started for this by Z-index/KNMP. For now, the following list will be used. This list will be replaced by a thesaurus in the G standard at a later stage.

List2.png AdministrationAgreementAdditionalInformationCodeList
ST.png NL-CM:9.8.22275 Arrowright.pngComment 0..1 Comments on the administration agreement.
48767-8 Annotation comment [Interpretation] Narrative

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

ToedieningsAfspraakDatumTijd Gebruiksperiode GeneesmiddelBijToedieningsafspraak Verstrekker GeannuleerdIndicator ToedieningsafspraakStoptype
Ingangsdatum Einddatum Duur ProductCode Zorgaanbieder
2-5-2012 12:14:09 02-05-12 4 weken Paracetamol tablet 500 mg Apotheek De Gulle Gaper
10-9-2015 9:16:31 5 dagen Pantoprazol injpdr 40 mg fl Apotheek De Gulle Gaper Ja
19-9-2014 7:12:59 19-09-14 18-12-14 Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml Poli-apotheek Het Ziekenhuis
30-8-2013 8:41:43 01-08-13 30-08-13 Prednison 5 mg Poli-apotheek Het Ziekenhuis Definitief
Gebruiksinstructie
Omschrijving ToedieningsWeg HerhaalperiodeCyclischSchema Doseerinstructie
Doseerduur Dosering|Keerdosis Toedieningsschema|Frequentie|Interval|Toedientijd|Weekdag|Dagdeel Zo nodig
Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag oraal 1 4 weken 1 stuk max. 4x/dag Bij pijn
Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st) iv 40 mg (=1 st) 1x per dag om 8.00 uur
Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml) subcutaan 2500 IE (=0,2 ml) 1x per dag om 18.00 uur
Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken. oraal 1

Valuesets

AdministrationAgreementAdditionalInformationCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.2 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
Geneesmiddel niet verstrekt 1 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Geneesmiddel niet verstrekt
Niet leverbaar 2 Voorlopige aanvullende  informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Niet leverbaar
Medicatieafspraak gewijzigd: substantie 3 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Medicatieafspraak gewijzigd: substantie
Medicatieafspraak gewijzigd: dosering 4 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Medicatieafspraak gewijzigd: dosering
Medicatieafspraak gewijzigd: farmaceutische vorm 5 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Medicatieafspraak gewijzigd: farmaceutische vorm
Medicatieafspraak gewijzigd: verwisseling van persoon 6 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Medicatieafspraak gewijzigd: verwisseling van persoon
Machtiging aangevraagd 7 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Machtiging aangevraagd
Machtiging afgewezen 8 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Machtiging afgewezen
Machtiging in gebruik nemen 9 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Machtiging in gebruik nemen
Gebruiksinstructie gegeven 10 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Gebruiksinstructie gegeven
Controle inhalatietechniek 11 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Controle inhalatietechniek
Meter periodieke controle 12 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Meter periodieke controle
Pen controle/omruil 13 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Pen controle/omruil
Bijwerking besproken 14 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Bijwerking besproken
Afhandeling bijwerking niet-lareb 15 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Afhandeling bijwerking niet-lareb
Melding lareb 16 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Melding lareb
Medicatiebewaking OT 17 Voorlopige aanvullende informatie toedieningsafspraak 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 Medicatiebewaking OT

AdministrationAgreementStopTypeCodeList

Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1 Binding: Extensible
Conceptname Conceptcode Codesystem name Codesystem OID Description
Tijdelijk 1 StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
Definitief 2 StopType 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 Het staken van een bestaande medicamenteuze behandeling.

This information model in other releases

Information model references

This information model refers to

This information model is used in

Technical specifications in HL7v3 CDA and HL7 FHIR

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

Downloads

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Prerelease 2018 #1
SNOMED CT and LOINC codes are based on:

  • SNOMED Clinical Terms version: 20180731 [R] (July 2018 Release)
  • LOINC version 2.64

Conditions for use are located on the mainpage List2.png
This page is generated on 23/12/2018 01:19:58 with ZibExtraction v. 3.0.6929.24609

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=AdministrationAgreement-v1.0.1(2018EN)&oldid=15319"